KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Edwards Lifesciences (EW) Non Operating Income (2016 - 2025)

Historic Non Operating Income for Edwards Lifesciences (EW) over the last 17 years, with Q3 2025 value amounting to $41.3 million.

  • Edwards Lifesciences' Non Operating Income fell 2088.12% to $41.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $146.9 million, marking a year-over-year increase of 124.05%. This contributed to the annual value of $169.4 million for FY2024, which is 16677.17% up from last year.
  • Latest data reveals that Edwards Lifesciences reported Non Operating Income of $41.3 million as of Q3 2025, which was down 2088.12% from -$11.0 million recorded in Q2 2025.
  • Over the past 5 years, Edwards Lifesciences' Non Operating Income peaked at $77.5 million during Q4 2024, and registered a low of -$11.0 million during Q2 2025.
  • Over the past 5 years, Edwards Lifesciences' median Non Operating Income value was $5.5 million (recorded in 2021), while the average stood at $17.7 million.
  • As far as peak fluctuations go, Edwards Lifesciences' Non Operating Income surged by 156666.67% in 2021, and later crashed by 24285.71% in 2022.
  • Quarter analysis of 5 years shows Edwards Lifesciences' Non Operating Income stood at $1.4 million in 2021, then surged by 1478.57% to $22.1 million in 2022, then surged by 140.72% to $53.2 million in 2023, then soared by 45.68% to $77.5 million in 2024, then tumbled by 46.71% to $41.3 million in 2025.
  • Its last three reported values are $41.3 million in Q3 2025, -$11.0 million for Q2 2025, and $39.1 million during Q1 2025.